Concepedia

Exposure-response Timing

Exposure-Response Timing is a temporal risk analysis construct that specifies the interval between initial exposure to a hazard and the onset of a measurable adverse outcome, distinguishing it from related risk assessment components by focusing explicitly on the temporal dynamics governing cause-effect latency in epidemiological and environmental health studies.

10

Publications

298

Citations

59

Authors

38

Institutions

Publications per year

2017–2026

4

Parents

Publications

10

Population pharmacokinetics and exposure–response of trametinib, a MEK inhibitor, in patients with BRAF V600 mutation-positive melanoma

Danièle Ouellet, Nastya Kassir, Joannellyn Chiu et al. · Cancer Chemotherapy and Pharmacology · 2016 · 57 citations

, , +17

Controlling silver nanoparticle exposure in algal toxicity testing – A matter of timing

Sara Nørgaard Sørensen, Anders Baun · Nanotoxicology · 2014 · 45 citations · Full text

, , +17

Exposure-Response Curve for Radiation-Induced Lung Tumors in the Mouse

John M. Yuhas, Alexander Walker · Radiation Research · 1973 · 34 citations

, , +17

Evaluation of the QT effect of a combination of piperaquine and a novel anti‐malarial drug candidate OZ439, for the treatment of uncomplicated malaria

Börje Darpö, Georg Ferber, Peter K. S. Siegl et al. · British Journal of Clinical Pharmacology · 2015 · 34 citations · Full text

, , +14

Penalized estimation of complex, non-linear exposure-lag-response associations

Andreas Bender, Fabian Scheipl, Wolfgang H. Hartl et al. · Biostatistics · 2018 · 34 citations

, , +16

1–5 of 10

Authors

59

  1. AA
    Abdelmonem A. Afifi

    University of California, Los Angeles, United States

    1 publications · 14 citations

    1

    h-index

  2. CL
    Cathrine Leonowens

    GlaxoSmithKline (United States), United States

    1 publications · 57 citations

    1

    h-index

  3. ZH
    Zhongqing He

    AstraZeneca (United Kingdom), United Kingdom

    1 publications · 16 citations

    1

    h-index

  4. BD
    Börje Darpö

    Karolinska Institutet, Sweden

    1 publications · 34 citations

    1

    h-index

  5. BL
    Bart Laurijssens

    Medicines for Malaria Venture, Switzerland

    1 publications · 34 citations

    1

    h-index

1–5 of 59

Institutions

38

  1. Jilin University

    Changchun, China

    1 h-index

    1 publications

    31 citations

  2. Sarah Cannon

    Nashville, United States

    1 h-index

    1 publications

    14 citations

  3. Kingston General Hospital

    Kingston, Canada

    1 h-index

    1 publications

    34 citations

  4. Technical University of Denmark

    Kongens Lyngby, Denmark

    1 h-index

    2 publications

    90 citations

  5. AstraZeneca (Australia)

    Macquarie Park, Australia

    1 h-index

    1 publications

    16 citations

  6. Purdue University West Lafayette

    West Lafayette, United States

    1 h-index

    2 publications

    38 citations

  7. National Cancer Institute

    Bethesda, United States

    1 h-index

    1 publications

    14 citations

  8. Incyte (United States)

    Wilmington, United States

    1 h-index

    4 publications

    228 citations

1–8 of 38

Venues

  1. Cancer Chemotherapy and Pharmacology

    2 publications · 73 citations

    2

    h-index

  2. Parasitology

    1 publications · 19 citations

    1

    h-index

  3. Biostatistics

    1 publications · 34 citations

    1

    h-index

  4. IEEE photonics journal

    1 publications · 31 citations

    1

    h-index

  5. Journal of Exposure Science & Environmental Epidemiology

    JESEE · 1 publications · 14 citations

    1

    h-index

1–5